Advantage Investment Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Advantage Investment Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-877	Closed	-$12K	–	1100
2017 Q3	$12K	Buy	+877	New	+$7.93K	﹤0.01%	664
2016 Q2	–	Sell	-500	Closed	-$3K	–	940
2016 Q1	$3K	Hold	500	–	–	﹤0.01%	752
2015 Q4	$3K	Hold	500	–	–	﹤0.01%	753
2015 Q3	$3K	Hold	500	–	–	﹤0.01%	729
2015 Q2	$3K	Hold	500	–	–	﹤0.01%	749
2015 Q1	$3K	Hold	500	–	–	﹤0.01%	757
2014 Q4	$3K	Buy	+500	New	+$3.68K	﹤0.01%	683

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advantage Investment Management's SPPI Position: Q4 2017 in Review

Advantage Investment Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 877 shares — an estimated $12K sold.

Advantage Investment Management first reported a position in SPPI in Q4 2014 and held it in 7 quarters. The position peaked at $12K in Q3 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

Advantage Investment Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Advantage Investment Management sold 877 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $12K.
Advantage Investment Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 7 quarters.
Advantage Investment Management's Spectrum Pharmaceuticals Inc position peaked at $12K in Q3 2017.
157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Advantage Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.